News | October 24, 2011

Image Guided Laser Therapy Creator Honored as Breast Cancer Leader

 

October 24, 2011 – Kambiz Dowlat, M.D., founder of Novian Health, has been honored by the Chicagoland-area affiliate of Susan G. Komen for the Cure in the inaugural class of Pink Tie Guys. Dowlat, developer of Novilase image-guided laser therapy for breast tumors, is one of what the organization called "an exclusive group of KoMEN making a difference in the fight against breast cancer."

The Pink Tie Guys, who were nominated by the community and selected by the Komen Chicagoland Board of Directors, were honored Oct. 13 at Tribune Media Group's Pink Tie Gala attended by Illinois Gov. Pat Quinn. In addition to Dowlat, former Chicago Mayor Richard M. Daley was among the honorees.

"This prestigious award demonstrates yet again the value of Dowlat's research. It's a gratifying recognition of his longstanding dedication to improving women's breast health,” said Henry "Chip" Appelbaum, president and CEO of Novian Health. Dowlat, a professor of surgery at Rush University Medical Center, is a pioneer of minimally invasive breast cancer procedures. He performed the groundbreaking research that formed the basis for the multi-center breast cancer trial that Novian is launching, having recently received approval of an investigational device (IDE) from the U.S. Food and Drug Administration (FDA). Novian developed the Novilase ILT System for the ablation of small (up to 20 mm) malignant breast tumors. The company has previously received FDA 510(k) clearance for the treatment of breast fibroadenomas and currently offers Novilase at breast centers around the country that are participating in its ABLATE registry.

The Chicagoland affiliate of Susan G. Komen for the Cure was established in 1997 and held the first Susan G. Komen Chicago Race for the Cure. The affiliate has awarded nearly $11 million towards the fight against breast cancer by funding grassroots breast health education and breast cancer screening and treatment projects, as well as national research.

For more information: www.novianhealth.com

 

Related Content

Theraclion to Launch Metastatic Breast Cancer Trial Combining Echotherapy and Immunotherapy
News | Focused Ultrasound Therapy | September 18, 2017
September 18, 2017 — Theraclion and co-lead investigator David Brenin, M.D., from the University of Virginia School o
DenseBreast-info.org Debuts  Spanish Language Video  About Dense Breasts
News | Breast Density | September 12, 2017
Breast cancer risks associated with breast density are the subject of a new Spanish language video launched recently by...
Asian Study Underlines Potential Value of Pressure-Guided Mammography
News | Mammography | September 11, 2017
Sigmascreening recently announced that a study of in total 15,898 in digital mammograms from 3,772 Asian women...
Delphinus Enrolls First Patient in Discover Breast Ultrasound Clinical Project
News | Ultrasound Womens Healthcare | September 08, 2017
September 8, 2017 — Delphinus Medical Technologies Inc.
Breast imaging X-ray mammogram showing a breast tumor. Photo courtesy of Monthian Ritchan-Ad

Photo courtesy of Monthian Ritchan-Ad

Feature | Breast Density | September 08, 2017 | By Roy Prager, M.D.
While mammograms play a vital role in efforts to identify breast cancer, they can present some challenges in women with...
FDA Clears Senographe Pristina Mammography System With Patient-Assisted Compression
Technology | Mammography | September 05, 2017
The U.S. Food and Drug Administration (FDA) cleared GE Healthcare’s Senographe Pristina with Self-Compression, the...
FDA Releases Six-Month Inspection Data From EQUIP Mammography Quality Initiative
News | Mammography | September 01, 2017
September 1, 2017 — The Division of Mammography Quality Standards (DMQS) of the U.S.
Hologic Announces Availability of Brevera Breast Biopsy System With CorLumina Imaging Technology
Technology | Breast Biopsy Systems | August 31, 2017
Hologic Inc. announced U.S. commercial availability of the Brevera breast biopsy system with CorLumina imaging...
China FDA Approves Xoft Axxent Balloon Applicators for Early-Stage Breast Cancer
News | Brachytherapy Systems, Women's Healthcare | August 30, 2017
iCAD Inc. announced that the company’s Xoft Axxent balloon applicators have received approval from the China Food...
Top list of stories, article, videos for breast imaging.
Feature | Breast Imaging | August 30, 2017 | Dave Fornell
August 30, 2017 — This is a list of the top breast imaging content so far for 2017.
Overlay Init